Health Trials

Tumor Grade

2

Review clinical trials related to Tumor Grade. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Poitiers University HospitalUpdated: May 8, 2026Locations: 1
Eligibility criteria

Age≥ 18 years, [+4]

Any contraindication to an MRI examination [+2]

Read more
Status: Not yet recruiting

Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score

To evaluated the prognostic significance of tumor grade in patients with node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2-negative breast cancers treated according to RS-guided strategies.

Participants needed: 4,000
Trial details
Age: 20+Biological sex: AllType: ObservationalSponsor: Gangnam Severance HospitalUpdated: Jul 30, 2025
Eligibility criteria

Patients with hormone receptor-positive, HER2-negative early-stage breast cancer [+2]

Patients with breast cancer under the age of 20 [+2]

Read more